How can we ameliorate irinotecan-associated diarrhea in children with poor compliance for oral cephalosporin?
Nariai
Hiroki
H
Shitara
Toshiji
T
Oto
Yuji
Y
Natsumeda
Tomo
T
Taniuchi
Mayumi
M
Sato
Yoshitake
Y
D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D003967:Diarrhea / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D000077146:Irinotecan; D008297:Male; D009447:Neuroblastoma / Q000628:therapy; D010349:Patient Compliance
D002511:Cephalosporins; D000077146:Irinotecan; D002166:Camptothecin